Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,330 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease.
Men CJ, Amarikwa L, Pham B, Sears C, Clauss K, Lee BW, Lee WW, Pasol J, Ugradar S, Shinder R, Cockerham K, Wester S, Douglas R, Kossler AL. Men CJ, et al. Among authors: douglas r. Ophthalmic Plast Reconstr Surg. 2024 May-Jun 01;40(3):276-285. doi: 10.1097/IOP.0000000000002564. Epub 2023 Nov 16. Ophthalmic Plast Reconstr Surg. 2024. PMID: 37972960
Histopathology of brow fat in thyroid-associated orbitopathy.
Hwang CJ, Khadavi NM, Papageorgiou K, Said J, Chong K, Lee D, Smith TJ, Goldberg RA, Douglas RS. Hwang CJ, et al. Ophthalmic Plast Reconstr Surg. 2012 Jan-Feb;28(1):27-9. doi: 10.1097/IOP.0b013e31822e9560. Ophthalmic Plast Reconstr Surg. 2012. PMID: 22082595
Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy leads to chemokine production.
Gillespie EF, Papageorgiou KI, Fernando R, Raychaudhuri N, Cockerham KP, Charara LK, Goncalves AC, Zhao SX, Ginter A, Lu Y, Smith TJ, Douglas RS. Gillespie EF, et al. Among authors: douglas rs. J Clin Endocrinol Metab. 2012 May;97(5):E740-6. doi: 10.1210/jc.2011-2514. Epub 2012 Mar 7. J Clin Endocrinol Metab. 2012. PMID: 22399514 Free PMC article.
Teprotumumab for the Treatment of Active Thyroid Eye Disease.
Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson EHZ, Perdok R, Fleming JC, Fowler BT, Marcocci C, Marinò M, Antonelli A, Dailey R, Harris GJ, Eckstein A, Schiffman J, Tang R, Nelson C, Salvi M, Wester S, Sherman JW, Vescio T, Holt RJ, Smith TJ. Douglas RS, et al. N Engl J Med. 2020 Jan 23;382(4):341-352. doi: 10.1056/NEJMoa1910434. N Engl J Med. 2020. PMID: 31971679 Clinical Trial.
1,330 results